were treated with the indicated DNA damaging agents or anti-Fas (B) Fas-Fc blocks DNA damage-induced cell death in 2B4 cells. The antibody, and cell death was determined after 12-16 hr by propidium murine T cell hybridoma, 2B4, was treated with etoposide (10 M) iodide uptake on FACS. or UVB (60 s) and cultured with . Cell death was (B) Jurkat T cells stably expressing IB␣M or the control vector were determined after 16 hr by propidium iodide uptake on FACS.
treated with etoposide (5 M), teniposide (5 M), or UVB (120 s), and FasL expression was determined by RT-PCR at the indicated times.
that Fas-Fc effectively blocked cell death induced by teniposide in Jurkat cells ( Figure 1A ). Similar results were obtained for etoposide and UVB (data not shown).
To examine this possibility, we utilized an IB mutant We also observed this inhibition of stress-induced apo-(IB␣M) that effectively blocks activation of NF-B inptosis in the murine T cell hybridoma 2B4 (Figure 1B) duced by either TNF or IL1 in a number of different cell and in concanavalin A-activated murine T cell blasts lines, including Jurkat cells (Van Antwerp et al., 1996) . (data not shown). Cell death was similarly blocked by As shown in Figure 2A , stable expression of IB␣M in neutralizing anti-Fas antibody (data not shown). Thus, Jurkat cells effectively inhibited apoptosis induced by competitive binding of either FasL (by Fas-Fc) or Fas etoposide, teniposide, or UV, but not by anti-Fas. This (by anti-Fas) effectively inhibited death induced by DNA inhibition of apoptosis corresponded to an inhibition of damaging agents in these cells.
stress-induced expression of FasL mRNA ( Figure 2B ). In contrast, and as previously shown (Van Antwerp et DNA Damaged-Induced Fas/FasL- Mediated al., 1996) , IB␣M overexpression increased the suscepApoptosis in Activated T Lymphocytes tibility to TNF-induced death (data not shown).
Proceeds via Activation of NF-B
The signals that are induced by stress often activate the DNA Damage-Induced FasL Promoter Activation transcription factor NF-B (Stein et al., 1993) . Indeed, Is Dependent on the Activation of NF-B treatment with either of the topoisomerase inhibitors A simple, unifying explanation for the above observainduced activity of an NF-B-dependent reporter and tions is that DNA damage and related stress can induce not a mutated NF-B reporter (data not shown). Previous the FasL promoter via the activation of NF-B. To test studies by ourselves and others had suggested that NFthis possibility, we employed a reporter construct in B can act as an inhibitor of apoptosis induced by TNF which luciferase gene expression is controlled by the but not by Fas (Beg and Baltimore, 1996; Liu et al., 1996;  5Ј flanking sequence (1.2 kb) from the human FasL gene. Van Antwerp et al., 1996; Wang et al., 1996) , and we
We cloned the 1.2 kb gene upstream of the initiation therefore sought to determine whether activation of NFcodon of the human FasL pro-B can either inhibit or promote stress-induced apoptosis, perhaps via effects on FasL expression.
moter by polymerase chain reaction (PCR). The 1.2 kb Figure 3C ). These data further support a role sion construct for p65 Rel at the indicated ratio. Reporter activity was determined after 12-16 hr.
for NF-B in driving activation of the FasL promoter following DNA damage or related stress.
In an attempt to identify the potential NF-B elements FasL promoter contains putative binding sites for sevin the FasL promoter, we examined the promoter seeral transcription factors including AP-1, NF-B, and quence and identified a putative atypical NF-B binding NFAT. We observed that this construct showed consissite (GGGGACTTTCT) in the FasL promoter that is similar tent activation in Jurkat cells treated with a combination to the site found in the ␤2-microglobulin promoter (Israel of phorbol esters and calcium ionophore as well as TCR et al., 1989) . Following treatment with etoposide, we ligation using anti-CD3 antibodies (data not shown), a examined nuclear extracts for NF-B binding activity by stimulus that induces FasL promoter activation in T cells an electromobility shift assay (EMSA), using the putative (Latinis et al., 1997) . We then examined the ability of DNA NF-B site from the FasL promoter. As shown in Figure  damaging agents to induce activity of this promoter. As 4A, etoposide treatment resulted in rapid activation of shown in Figure 3A , treatment of Jurkat cells with either NF-B binding activity. The binding to this site was cometoposide or teniposide induced activation of the FasL peted by a consensus NF-B motif (Lenardo and Baltipromoter. This activation was not seen with a similar more, 1989) ( Figure 4A ) and not by an irrelevant oligonuconstruct including only 0.9 kb of the FasL promoter.
cleotide (data not shown). Putative binding sites for NF-B and AP-1 were present
We then performed site-directed mutagenesis to alter in the region between 0.9 and 1.2 kb, and we speculated this site in the promoter and tested for the ability of the that these might participate in DNA damage-induced mutant FasL promoter to be induced upon treatment FasL expression and apoptosis (see below).
with DNA damaging agents. As shown in Figure 4B , this To test the effect of inhibition of NF-B activation on single nucleotide substitution abolished the ability of stress-induced FasL promoter activity, we cotransthis promoter to be induced by coexpression of the p65 fected Jurkat cells with the 1.2 kb FasL promoter resubunit of NF-B. Further, the mutant FasL promoter porter construct plus either wild-type IB or IB␣M. As was no longer induced by treatment with either etoposhown in Figure 3B , either form of IB effectively blocked side or teniposide ( Figure 4C ). Together with the results the activation of the FasL promoter by DNA damaging described above, we conclude that NF-B is a key mediagents. These also inhibited basal activity of the promoter. It is therefore likely that NF-B is required for ator of stress-induced FasL expression.
pathway . Expression of this DN-MEKK1 in Jurkat cells was shown to significantly inhibit JNK activity without affecting the ERK kinases (Faris et al., 1996) . Under conditions in which DN-MEKK1 was expressed, apoptosis induced by either etoposide or teniposide was dramatically inhibited (71%-72% apoptosis was decreased to 25%-32% apoptosis, data not shown). In contrast, Fas-mediated apoptosis was unaffected by the expression of DN-MEKK1 (90% versus 96% apoptosis, data not shown). Thus, DNA damageinduced apoptosis in Jurkat T cells appears to be dependent upon the function of MEKK1 or other family members. Since we observe activation of JNK but not of ERK, it is likely that the effects of DN-MEKK1 represent a role for the JNK pathway in this form of apoptosis. We then examined the effects of inhibition of this pathway on stress-induced FasL promoter activation. The 1.2 kb FasL promoter reporter construct described above was cotransfected with dominant-negative inhibitors of the SAPK/JNK pathway, and cells were treated with DNA damaging agents. As shown in Figure 5B , coexpression with either catalytically inactive DN-MEKK1 (K432M) or DN-JNKK (K116R) inhibited stress-induced FasL promoter activity. proteins that were competed by the consensus AP-1-binding sequence but not by a mutant sequence ( Figure  6A ). Based on these findings, we cotransfected cJun Activation of the SAPK/JNK Pathway Is Required and/or cFos together with the 1.2 kb FasL promoter for DNA Damage-Induced FasL Expression reporter construct as described above. As shown in and Apoptosis in Jurkat T Cells Figure 6B , coexpression of Fos/Jun increased the proTo examine the role of the SAPK/JNK pathway in stressmoter activity considerably. To determine whether this induced FasL expression, we first confirmed that this AP-1 site is important in stress-induced FasL exprespathway is engaged following such treatments. Treatsion, we then introduced mutations into this site in the ment of Jurkat T cells with UVB, etoposide, or teniposide FasL promoter and examined its effects. As shown in induced activation of JNK (data not shown), as de- Figure 6C , mutation of the AP-1 site completely abroscribed for other cell lines (Liu et al., 1996 ; Seimiya gated teniposide-induced FasL promoter activity, strongly et al., 1997). In contrast, treatment with etoposide or suggesting that this site is essential for stress-induced teniposide had no effect on the activity of ERK (data activation of the promoter. not shown). The Fas-Fc chimeric protein that blocked apoptotic death had no effect on the increase in JNK activity ( Figure 5A ), suggesting that the activation of Discussion JNK occurs upstream of Fas/FasL interaction. Thus, as for UV and ␥ irradiation (Hibi, 1993; , expo-DNA Damage-Induced Apoptosis Can Require sure to topoisomerase inhibitors triggers the activation Signal Transduction Events Leading of the SAPK/JNK pathway, following which FasL is exto Gene Expression pressed.
In T cells and T cell lines, cytotoxic agents that damage To determine whether activation of the SAPK/JNK DNA initiate a signaling pathway that involves the activapathway participates in stress-induced apoptosis, we tion of NF-B and AP-1, which in turn promote the apoused a conditional gene expression system in which ptotic death of the cell. It is well established that AP-1 expression of a dominant-negative (DN) mutant of is induced via activation of the SAPK/JNK pathway (Kal-MEKK1 (K432M) (Rosette and Karin, 1996) . NF-B can also be activated via other pathways, many of which do not affect cell survival or death. Thus, how this transcription factor might contribute to the apoptotic process has remained elusive. Similarly, apoptosis induced in some cells by UV, ionizing radiation, and chemotherapeutic drugs can be inhibited by blocking the SAPK/JNK signaling pathway , although apoptosis induced by TNF may or may not depend on this pathway (Liu et al., 1996; Verheij et al., 1996) , perhaps depending on the cell type being studied. This requirement of the SAPK/JNK pathway for some forms of apoptosis is most easily explained if the process of apoptosis requires transcription that is controlled by a factor, such as AP-1, ATF-2, or NF-B, that is in turn regulated by the SAPK/JNK pathway. A similar case can be made for most other signaling events or molecules that have been implicated in apoptosis.
Transcription factors such as c-Myc (Evan et al., 1992; Amati et al., 1993; Hermeking and Eick, 1994) , p53 (Kuerbitz et al., 1992; Fritsche et al., 1993) , IRF-1 (Tanaka et (Yonehara et al., 1989; Itoh et al., 1991) . Brunner et al., 1995 Brunner et al., , 1996 Dhein et al., 1995 ; Ju from DNA damage through the SAPK/JNK pathway, to et al., 1995), as well as upon DNA damage in these cells activation of AP-1 and NF-B, to expression of FasL (Friesen et al., 1996; Reap et al., 1997 ; our present work). and subsequent Fas-mediated apoptosis.
Similarly, induction of Fas expression in cells that exRecently, Faris and colleagues found that ectopic express FasL will also lead to apoptosis, and this has pression of a constitutively active MEKK leads to apobeen shown to be a mechanism whereby IL1 induces ptosis and expression of FasL in Jurkat cells (Faris et apoptosis in thyrocytes (Giordano et al., 1997) . A third al., 1998). This apoptosis was inhibited by blocking Fas/ way in which transcription could influence apoptosis in FasL interactions. Thus, activation of the SAPK/JNK this system is via alteration of susceptibility to Faspathway either by stress or by other means can result mediated apoptosis, perhaps through regulated tranin activation of the FasL promoter via AP-1. Whether the scription of the signal transduction components enactivation of FasL expression and apoptosis by active gaged upon ligation of Fas, or control of inhibitors of MEKK is also dependent on NF-B function is not this signaling complex. Susceptibility to Fas-induced known, but some reports suggest that NF-B can be death is clearly regulated (Boldin et al., 1995 (Boldin et al., , 1996 ; induced by this pathway (Lee et al., 1997). We suspect Muzio et al., 1996) , and in one case, this susceptibility that stress-induced activation of AP-1 and NF-B, leadhas been shown to be enhanced by expression of c-Myc ing to FasL expression and apoptosis, are linked via (Hueber et al., 1997) . Further, in the analogous process signaling pathways, with both elements required for opwhere apoptosis is induced by TNF, susceptibility has timal expression.
been shown to be inhibited by NF-B (Beg and Balti-A number of cytotoxic stressors, including UV, ionizing radiation, chemotherapeutic drugs, and TNF, induce more, 1996; Van Antwerp et al., 1996; Wang et al., 1996) and enhanced by c-Myc (Janicke et al., 1996) , as well were more resistant to induction of apoptosis by low doses of etoposide than were those as by Ras (Trent et al., 1996) .
From this perspective, it is interesting to observe that from wild-type controls (data not shown). However, at higher doses of etoposide (greater than 50 M) no differactivation of NF-B is required for stress-induced expression of FasL (Figure 2 ). In the same cells, inhibition ence in the extent of apoptosis was seen (data not shown). Thus, in these T cells other mechanisms of DNA of NF-B activation sensitized cells to apoptosis induced by TNF, although this did not affect susceptibility damage-induced apoptosis appear to be recruited to ensure that cell death occurs. This is consistent with to Fas-mediated apoptosis in these cells (Van Antwerp et al., 1996) , suggesting a differential role for NF-B in the observation of others (Reap et al., 1997) , who found that T cells from gld mice were relatively resistant to apoptosis. It has been shown that a series of topoisomerase poisons (etoposide, camptothecin, ara-C) also acapoptosis triggered by ␥ irradiation. We therefore do not propose that the expression of tivate NF-B and induce apoptosis (Bessho, 1994; Piret and Piette, 1996) , and our results suggest that this is FasL and subsequent ligation of Fas is the only mechanism of DNA damage-induced apoptosis, nor the only important for the subsequent death of the cell.
We have identified an atypical NF-B binding site, one that may be regulated by NF-B and the SAPK/JNK pathway. Nevertheless, our studies do indicate that this GGGGACTTTCT, in the FasL promoter that is similar to the site found in the ␤2 microglobulin promoter (Israel is one way that this signal transduction pathway can contribute to the apoptotic response, and suggest addiet al., 1989) and that we found to be responsible for the effects of NF-B on the FasL promoter. Thus, it is tional candidates for similar transcriptional activation. Further, we do not suggest that this pathway is exclusive possible that the contrasting effects of NF-B activation on preventing TNF-induced apoptosis but promoting to activated T cells, since other cell types are capable of expressing FasL and can undergo Fas-mediated apoexpression of FasL (and thus Fas-mediated apoptosis) represent a fail-safe mechanism to ensure lymphocyte ptosis Muller et al., 1997) . The elucidation of this pathway not only gives us insights into the death in response to cytotoxic stress. As mentioned in the Introduction, the importance of eliminating potenrelationships between stress, signal transduction events, caspase activation, and apoptosis, but also provides a tially damaged lymphocytes might require multiple mechanisms of apoptosis.
number of ways in which we can interfere with, or enhance, the response of some cells to cytotoxic stress. dothelial cells is independent of p53, but dependent study. The T cell hybridoma 2B4 has been described previously upon functional acidic sphingomyelinase (Santana et (Yang et al., 1995) . All cells were grown in RPMI 1640 medium al., 1996) . This enzyme is activated upon ligation of Fas containing 10% fetal calf serum, 2 mM L-glutamine, and 100 U/ml each of penicillin and streptomycin (complete medium). Phorbol- (Cifone et al., 1993; Gulbins et al., 1995) , and it has been myristate acetate (PMA) was purchased from Sigma (St. Louis, MO) suggested that its activity is important for Fas-mediated and ionomycin from Calbiochem (La Jolla, CA). Mouse anti-human apoptosis in some cells. It will therefore be interesting CD3 (OKT3) antibody and hamster anti-mouse CD3⑀ (145-2C11) was to determine the role of stress-induced Fas/FasL interpurified from the culture supernatant by protein A affinity chromaactions leading to apoptosis in these and other nontography. Anti-mouse CD95(Jo.2) was purchased from Pharmingen lymphoid cells.
(San Diego, CA). Fas-Fc was produced by baculovirus expression system and purified using protein G affinity chromatography as It seems remarkable that any cell would use such a described (Brunner et al., 1995) . roundabout mechanism to mediate the apoptotic response to DNA damage. Even if the regulation of cell with anti-CD3 antibody (2C11) in 50 mM Tris (pH 9.0). PMA and ionomycin were added at concentrations of 50 ng/ml and 0.5 g/ml, Use of a cell surface receptor/ligand pair to activate respectively. UV radiation was used at 40-100 J/m 2 . DNA damaging caspases might provide an additional fail-safe mechadrugs etoposide (Sigma) and teniposide (Bristol-Myers Squibb) were nism to ensure that death occurs. Since cells that unused at 1-100 M concentration. Anti-Fas antibody (CH-11; Kamiya dergo cytotoxic stress are likely to be in the environment Biomedical Lab) was used at 1-500 ng/ml concentration. of other cells facing the same stress, a cell that might avoid undergoing apoptosis through failing to express
Assessment of Apoptosis sufficient amounts of functional FasL may nevertheless
In most experiments, apoptosis was assessed by staining with Annexin V-FITC (BioWhittaker) plus propidium iodide and analyzed undergo apoptosis through interaction with a FasLby FACS. In cotransfection experiments using tetracycline-repressexpressing neighbor. In this way, possible escape from able DN-MEKK (Faris et al., 1996) , cells were grown in complete DNA damage-induced apoptosis might be minimized. medium with or without 0.1 g/ml tetracycline (Sigma, St. Louis, This is not to say that this is the only pathway of MO). After 40 hr, cells were activated with the DNA damaging drugs cell death available to a T cell that has sustained DNA etoposide, teniposide, and anti-Fas antibody (Kamiya Biomedical damage. We observed that T cell blasts from animals Lab) for 6-8 hr, pelleted at 1-2 ϫ 10 6 /ml in PBS, and stained with Hoechst 33258 (Sigma) for 10 min at room temperature in the dark.
(gld mice) with functionally defective FasL expression Cells were then analyzed by fluorescence microscopy (Nikon Optoto normalize the transfection efficiencies in the various cotransfections. 40 hr posttransfection, cells were treated with the DNA damagphoto) for apoptosis as assessed by nuclear condensation and fragmentation in the GFP-transfected cells.
ing agents etoposide or teniposide and incubated for another 12-18 hr. Cells were harvested, washed three times with PBS, and lysed in 100 l of the lysis buffer. Cell debris was removed by centrifugaFasL Reporter Constructs tion, and the supernatant was used in the luciferase assay using a A genomic clone of human FasL containing the putative promoter Monolight 2010 luminometer (Analytical Luminescence Laboratory). region was generously provided by Dr. S. Nagata. An approximately 8 kb HindIII fragment containing the 5Ј promoter region was then Electromobility Shift Assays subcloned into a eukaryotic expression vector HsLuc (Tillman et al.,
DNA binding reactions were carried out for 20 min at 4ЊC in a buffer 1993) carrying a luciferase reporter gene downstream of the cloned containing 50 mM HEPES (pH 7.8), 20 mM MgCl2, 0.5 mM EDTA, 20 fragment. Using overlapping primers and automated DNA sequencing mM spermidine, 500 g/ml BSA, 10 mM DTT, 75% glycerol, and 10 4 (Core facility, SDSU, San Diego), we sequenced 2 kb upstream of counts per minute of labeled probe. The probes used were doublethe translational start site, which revealed potential binding sites for stranded synthetic oligonucleotides (Retrogen, San Diego, CA) repseveral transcriptional factors including the reported "housekeeping" resenting AP-1 and NF-B sites from the human FasL promoter: promoter elements and NFAT binding sites  hFasL-NF-B 5Ј-AAGCCTGGGCAACATAGAAAGTCCCCATCTGTA Latinis et al., 1997 ). Using PCR, we then obtained truncations of the CAAAAA-3Ј, and hFasL AP-1 5Ј-AAAAAGAATAAATTAGTCAGG TGT FasL promoter region and subcloned these into the HsLuc vector AGTGACTTATGCCTC-3Ј. Each strand was labeled separately with 5Ј of the luciferase reporter gene. The forward primers used for the T4 polynucleotide kinase (BRL) and [␥-32 P]ATP (5000 Ci/mmol), and 1.2 kb and the 0.9 kb gene were 5Ј-CCCAAGCTTCTGATATTTCAAA the strands were then allowed to reanneal slowly. The samples were ACAGAATAGGAA-3Ј primer 1 and 5Ј-CCCAAGCTTACTGGTTTGCA analyzed on a 4% nondenaturing acrylamide gel in 0.5% TBE. In GCCTTCTGATCTA-3Ј primer 2, respectively. The reverse primer some experiments, nuclear extracts from Jurkat cells were made 5Ј-ACGCGTCGACGGCAGCTGGTGAGTCAGGCCAGCC-3Ј primer 3 as described (Rosette and Karin, 1995) . Binding reactions contained was used for both amplifications. A 1.2 kb fragment and a 0.9 kb 5-10 g of nuclear extract, 32 P-labeled probe (25,000 cpm), and 2 fragment of the hFasL promoter were subsequently used in the g of poly dI:dC in the binding buffer. experiments described here. The mutations in the Ϫ1080 kB site were introduced using the Gene Editor kit (Promega) and in the Ϫ1048 AP-1 site using the Transformer site-directed mutagenesis kit Acknowledgments (Clonetech), and both constructs were sequenced using automated sequencing (Applied Biosystems).
We are grateful to Dr. S. Nagata for providing us with the hFasL genomic DNA, Drs. M. Faris and A. Nel for a conditionally expressed DN-MEKK, and Dr. D. Van Antwerp for the IB␣M-expressing cell RT-PCR for FasL Expression line. We would like to thank Dr. M. Karin for helpful discussions and The expression of FasL was determined by reverse transcription Drs. Ruth Kluck, Helen Beere, and Tesu Lin for critical review of the (RT) of total RNA followed by reverse transcription-PCR analysis manuscript. This work was supported by NIH grants GM 52735 and (RT-PCR). Approximatively 3 ϫ 10 6 Jurkat cells were homogenized CA 69831 to D. R. G. This is publication #195 from LIAI. with 1 ml of Trizol reagent (GIBCO-BRL), and total RNA was isolated according to the manufacturer's protocol. cDNAs were synthesized Received November 24, 1997; revised December 29, 1997. by extension of (dT) primers with 200 U of SuperScript II reverse transcriptase (GIBCO) in a mixture containing 1 g of total RNA digested by RNase-free DNase (2 U/g of RNA) for 15 min at 37ЊC. References PCR of the cDNA was performed in a final volume of 50 l containing all four dNTPs, 2 mM MgCl2, 2.5 U of AmpliTag (GIBCO), and each Alderson, M.R., Tough, T.W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K.A., Goodwin, R.G., Smith, C.A., Ramsdell, F., and Lynch, primer at 0.2 M using the geneAmp 2400 PCR system (Perkin Elmer). The amplification cycles were 94ЊC for 1 min, 55ЊC for 1 D.H. (1995) . Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181, 71-77. min, and 72ЊC for 1 min. The PCR products were separated by electrophoresis on a 1.5% agarose gel after 30-40 cycles (471-bp Amati, B., Littlewood, T.D., Evan, G.I., and Land, H. (1993) . The human FasL fragment) or after 25-30 cycles (661-bp human ␤-actin) c-Myc protein induces cell cyle progression and apoptosis through and visualized by ethidium bromide staining. Amplification of ␤-actin dimerization with Max. EMBO J. 12, 5083-5087. served as control for sample loading and integrity. The following Anel, A., Buferne, M., Boyer, C., Schnitt-Verhulst, A.-M., and primers were designed to discriminate between the amplification Golstein, P. (1994) . T cell receptor-induced Fas-ligand expression of cDNA and contaminating genomic cDNA: hFasL-Forward, TAA in cytotoxic T lymphocyte clones is blocked by protein tyrosine AACCGTTTGCTGGGGC; hFasL-Reverse, CTCAGCTCCTTTTTTTC kinase inhibitors and cyclosporin A. Eur. J. Immunol. 24, 2469-2476. AGGGG; ␤-actin-Forward, TGACGGGGTCACCCACACTGTGCC CA Ashwell, J.D., Cunningham, R.E., Noguchi, P.D., and Hernandez, D. TCTA; and ␤-actin-Reverse, CTAGAAGCATTTGCGGTGGACG ATG (1987) . Cell growth cycle block of T cell hybridomas upon activation GAGGG.
with antigen. J. Exp. Med. 165, 173-194. Beg, A.A., and Baltimore, D. (1996) . An essential role for the NFB Expression Vectors and Transient Transfections in preventing TNF-␣-induced death. Science 274, 782-784. A conditional expression vector for DN-MEKK was generously pro- Bessho, R. (1994) . Pyrrolidinedithiocarbamate, a potent inhibitor of vided by Drs. M. Faris and A. Nel (Faris et al., 1996) . Expression nuclear factor B (NFB) activation, prevents apoptosis in human vectors for Sr␣ c-fos, c-jun, p65, IB, and IB␣M were as previously promyelocytic leukemia HL-60 cells and thymocytes. Biochem. described (Mercurio et al., 1993; DiDonato et al., 1996) . Jurkat T Pharmacol. 48, 1883-1889. cells containing stably transfected SV40 large T antigen were elecBoland, M., Foster, S., and O'Neill, L. (1997) . Daunorubicin activates troporated as described previously (Kasibhatla et al., 1993) . Briefly, NFB and induces B-dependent gene expression in HL-60 promy-1.5-2 ϫ 10 7 cells were washed twice with serum-free RPMI 1640 elocytic and Jurkat T lymphoma cells. J. Biol. Chem. 272, 12952-medium, resuspended in 500 l of the same medium and transferred 12960. to 4 mm gap electroporation cuvettes (BioRad). 20-60 g of HsLuc Boldin, M.P., Varfolomeev, E.E., Pancer, Z., Mett, I.L., Camonis, J.H., FasL promoter alone or with Sr␣ c-fos, c-jun, p65, IB, or IB␣M and Wallach, D. (1995) . A novel protein that interacts with the death expression vectors (Mercurio et al., 1993; DiDonato et al., 1996) domain of Fas/APO1 contains a sequence motif related to the death were added to the cells and mixed well. Electroporation was carried domain. J. Biol. Chem. 270, 7795-7798. out at 250 V and 960 F in a Bio-Rad Gene Pulse II.
The 1.2 kb hFasL promoter construct was transfected with or Boldin, M.P., Goncharev, T.M., Goltsev, Y.V., and Wallach, D. (1996) . Involvement of MACH, a novel MORT1/FADD-interacting protease, without the coexpression vectors. pCMV ␤-galactosidase was used
